Ethacizine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ethacizine (ethacyzine) is a class Ic antiarrhythmic agent, related to moracizine. It is used in Russia and some other CIS countries for the treatment of severe and/or refractory ventricular and supraventricular arrhythmias, especially those accompanied by organic heart disease. It is also indicated as a treatment of refractory tachycardia associated with Wolff–Parkinson–White syndrome.^[1]

It is manufactured under the brand name Ethacizin (Этацизин) by Olainfarm.^[2]

References

↑ ^1.0 ^1.1 “Этацизин (Ethacyzin) Prescribing Information. VIDAL Drug Compendium” (in Russian). Retrieved 5 February 2014.
↑ “Этацизин—4DOKTOR.RU Drug Information Handbook” (in Russian). Retrieved 5 February 2014.

Template:Antiarrhythmic agents

[PI-1] 1.0 ^1.1 “Этацизин (Ethacyzin) Prescribing Information. VIDAL Drug Compendium” (in Russian). Retrieved 5 February 2014.

[2] “Этацизин—4DOKTOR.RU Drug Information Handbook” (in Russian). Retrieved 5 February 2014.

[1]

[2]